Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Oct;25(5):350-7.
doi: 10.1097/MOL.0000000000000110.

Sortilin and lipoprotein metabolism: making sense out of complexity

Affiliations
Review

Sortilin and lipoprotein metabolism: making sense out of complexity

Alanna Strong et al. Curr Opin Lipidol. 2014 Oct.

Abstract

Purpose of review: Genome-wide association studies have been used as an unbiased tool to identify novel genes that contribute to variations in LDL cholesterol levels in the hopes of uncovering new biology and new therapeutic targets for the treatment of atherosclerotic cardiovascular disease. The locus identified by genome-wide association studies with the strongest association with LDL cholesterol and atherosclerotic cardiovascular disease is the 1p13 sortilin-1 (SORT1) locus. Here, we review the identification and characterization of this locus, the initial physiological studies describing the role of SORT1 in lipoprotein metabolism, and recent work that has begun to sort out the complexity of this role.

Recent findings: Studies by several groups support an important role for sortilin in lipoprotein metabolism; however, the directionality of the effect of sortilin on plasma cholesterol and its role in the secretion of hepatic lipoproteins remains controversial. Studies by several groups support a role for sortilin in inhibiting lipoprotein export, whereas other studies suggest that sortilin facilitates lipoprotein export.

Summary: Understanding the mechanism by which sortilin affects LDL cholesterol will increase our understanding of the regulation of lipoprotein metabolism and hepatic lipoprotein export and may also allow us to harness the power of the 1p13 SORT1 locus for the treatment of atherosclerotic cardiovascular disease.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest relevant to this article to report.

Figures

Figure One
Figure One
Potential models to reconcile the overexpression and deficiency data
Figure One
Figure One
Potential models to reconcile the overexpression and deficiency data
Figure One
Figure One
Potential models to reconcile the overexpression and deficiency data

Similar articles

Cited by

References

    1. Lloyd-Jones D, et al. Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation. 2010;121(7):948–954. - PubMed
    1. Lusis AJ. Atherosclerosis. Nature. 2000;407(6801):233–241. - PMC - PubMed
    1. Hobbs H, Rader DJ. In: Lipoprotein Metabolism, in Harrison's Principles of Internal Medicine. Kasper D, Braunwald E, Fauci AS, editors. New York: McGraw Hill Publishers; 2007. pp. 2416–2429.
    1. Kathiresan S, et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet. 2008;40(2):189–197. - PMC - PubMed
    1. Willer CJ, et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet. 2008;40(2):161–169. - PMC - PubMed

Publication types

MeSH terms